Response to 'Hydrocortisone suspension formulations are not necessarily the same in the treatment of children with congenital adrenal hyperplasia'

Eur J Endocrinol. 2020 Dec;183(6):L29-L30. doi: 10.1530/EJE-20-1047.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adrenal Hyperplasia, Congenital* / drug therapy
  • Child
  • Drug Compounding
  • Humans
  • Hydrocortisone*

Substances

  • Hydrocortisone